Effectiveness of Chloral Hydrate on Brain MRI in Children with Developmental Delay/Intellectual Disability Comparing with Normal Intelligence: Single Tertiary Center Experience
Neurodiagnostic investigation requirements are expanding for diagnostic and therapeutic purposes in children, especially in those with developmental delay/intellectual disability (DD/ID). Thus, determination of optimal sedatives to achieve successful sedation and immobility without further neurologi...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_be9b38e14c47477c9bc48b23f1ed8736 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Ja Un Moon |e author |
700 | 1 | 0 | |a Ji Yoon Han |e author |
245 | 0 | 0 | |a Effectiveness of Chloral Hydrate on Brain MRI in Children with Developmental Delay/Intellectual Disability Comparing with Normal Intelligence: Single Tertiary Center Experience |
260 | |b MDPI AG, |c 2021-11-01T00:00:00Z. | ||
500 | |a 10.3390/children8121097 | ||
500 | |a 2227-9067 | ||
520 | |a Neurodiagnostic investigation requirements are expanding for diagnostic and therapeutic purposes in children, especially in those with developmental delay/intellectual disability (DD/ID). Thus, determination of optimal sedatives to achieve successful sedation and immobility without further neurological compromise is important in children with DD/ID. The purpose of this study is to assess the effectiveness and adverse reactions of chloral hydrate (CH) for brain magnetic resonance imaging (B-MRI) in children with DD/ID compared to those with normal intelligence (NI). We performed a retrospective chart review of children aged from 1 day to 12 years who required elective sedation using CH for B-MRI. About 730 cases (415 with DD/ID and 315 with NI) of CH sedation were conducted for B-MRI. Children with DD/ID showed a higher failure rate (22%) than did those with NI (6%); additional CH and prolonged sedation time were required. There was no difference in incidence of adverse reactions between DD/ID and NI groups (<i>p</i> = 0.338). Older or heavier children with DD/ID (<i>p</i> = 0.036 and <i>p</i> = 0.013, respectively), as well as those diagnosed with epilepsy or neuropsychiatric disorders showed higher risk of sedation failure (<i>p</i> < 0.001 for each). In conclusion, CH was a suboptimal sedative drug for children with DD/ID compared with those with NI. Other alternative or supplementary sedatives should be taken into consideration especially for those vulnerable groups. | ||
546 | |a EN | ||
690 | |a chloral hydrate | ||
690 | |a developmental delay | ||
690 | |a intellectual disability | ||
690 | |a sedative | ||
690 | |a children | ||
690 | |a Pediatrics | ||
690 | |a RJ1-570 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Children, Vol 8, Iss 12, p 1097 (2021) | |
787 | 0 | |n https://www.mdpi.com/2227-9067/8/12/1097 | |
787 | 0 | |n https://doaj.org/toc/2227-9067 | |
856 | 4 | 1 | |u https://doaj.org/article/be9b38e14c47477c9bc48b23f1ed8736 |z Connect to this object online. |